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The diuretic activity of a number of plant extracts used as diuretic agents in ethnomedicine has been
conﬁrmed in experimental animals. However, despite the widespread use of Peganum harmala in
traditional medicine, there is a paucity of data supporting its use as a diuretic agent. Therefore,
the present study aimed to envisage the true effect and magnitude of diuresis of methanolic extract
of P. harmala (MEPH) in comparison with a well-known diuretic drug furosemide using Wistar
albino rats. MEPH was administered orally in three different doses (150, 300 and 450 mg/kg) to
experimentally dehydrated rats. Furosemide (10 mg/kg orally) was used as a reference drug. The
diuretic effect of the MEPH was evaluated by measuring urine volume, urine pH, urinary electrolyte
levels, natriuretic and saliuretic effects. The urine volume (in mL) measured at 5 h and 24 h and
electrolyte excretion (Na+, K+, and Cl) at 24 h duration were measured. The urine output and
urinary electrolyte excretion were found to be signiﬁcantly higher in rats treated with MEPH as
compared to normal rats in a dose dependent manner (P< 0.05). The results of our study were
comparable to furosemide drug. Based on observed results, we can recommend that P. harmala
may be an effective diuretic, however, toxicity studies should be conducted before administration.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Medicinal plants play an important role in traditional medi-
cine for therapeutic purposes. Peganum harmala L. (Zygophyl-
laceae), also known as Assyrian Rue, used in traditional
medicine from ancient times, is considered an important
medicinal plant for the treatment of a variety of human ail-
ments (Chopra et al., 1957). It is rich in alkaloids and contains
up to 4% total alkaloids (Muhi-eldeen et al., 2008;
750 F.I. Al-Saikhan, M.N. AnsariAsgarpanah and Ramezanloo, 2012; Chopra et al., 1957;
Berrougui et al., 2006; Asghari and Lockwood, 2002; Arshad
et al., 2008).
The diuretic activity of a number of plant extracts used as
diuretic agents in ethnomedicine has been conﬁrmed in exper-
imental animals (Berrougui et al., 2006; Asgarpanah and
Ramezanloo, 2012). However, in spite of the widespread use
of P. harmala in traditional medicine, there is a paucity of data
supporting its use as a diuretic.
Diuretics, either alone or in combination with other drugs,
are effective in the treatment of hypertension, congestive heart
failure, ascites, and pulmonary edema (Gupta and Neyses,
2005). Plant extracts are commonly used in traditional medi-
cine for the treatment of some renal diseases, because of their
signiﬁcant diuretic activity (Berrougui et al., 2006). There is
uncertainty about the efﬁcacy of P. harmala as diuretic agent.
Hence, this study aimed at evaluating the acute diuretic, sali-
uretic, and natriuretic effects of orally administered methano-
lic extract of P. harmala seeds in normal rats.
2. Materials and methods
2.1. Preparation of plant extract
The seeds of P. harmala were purchased from the local market
of Al-Kharj, Kingdom of Saudi Arabia. The seeds were then
examined and authenticated.
The seeds were cleaned and a ﬁne powder (100 g) was
extracted with methanol (700 mL) by Soxhlet extraction. The
extract was ﬁltered and dried at room temperature.
2.2. Animals
Adult Wistar albino rats of either sex weighing 150–180 g were
used. The study protocol was approved by the Institutional
Animal Ethics Committee of the College of Pharmacy, Prince
Sattam Bin Abdulaziz University, KSA. The animals were
kept under standard laboratory conditions, with food and
water ad libitum, under a 12 h light/12 h dark cycle.
2.3. Chemicals
Methanol was purchased from Scharlab, S.L. Spain, Furose-
mide was obtained from Sigma–Aldrich, USA. All other chem-
icals used were of reagent grade.
2.4. Diuretic activity
Wistar albino rats were randomly divided into ﬁve groups of
six rats each. Control group, furosemide treated group, and
P. harmala treated group. Control group was treated with
2 ml/100 g of body weight methanol vehicle, furosemide trea-
ted group was treated with furosemide 10 mg/kg orally (Da
Silva et al., 2015; Hailu and Engidawork, 2014). Herbal treated
group was subdivided into three subgroups, they were treated
with 150, 300 and 450 mg/kg doses of methanolic extracts of P.
harmala (MEPH), respectively. All administered drugs were
given orally.
Each animal was placed in isolation in metabolic cages,
24 h prior to commencement of the experiment for adaptationand then fasted overnight with free access to water. Urine sam-
ples were collected after 5 h and 24 h of the last dose. The urine
samples were ﬁltered and ﬁnally stored at 20 C for elec-
trolyte analyses.
2.5. Measurement of urine parameters
Total urine volume was measured after 5 h and 24 h for all
rats. Urine pH and conductivity of fresh urine samples were
measured with a digital pH meter and conductivity meter,
respectively. The total urine output samples (24 h) were then
diluted (1:1000 in deionized water) to estimate the total con-
centrations of electrolytes (sodium, potassium, and chloride
ions) in urine (Hailu and Engidawork, 2014).
2.6. Diuretic action and activity
The diuretic action and diuretic activity were derived from the
ratio of urine volume in the test group and that in the control
and positive control groups, respectively. It was decided prior
to the start of the experiment that diuretic activity will be con-
sidered ‘‘nil”, ‘‘little”, ‘‘moderate”, and ‘‘good”, if the values
were <0.72, 0.72–1.00, 1.00–1.5, and >1.5, respectively
(Hailu and Engidawork, 2014).2.7. Saliuretic, natriuretic and carbonic anhydrase inhibition
The sum of Na+ and Cl urinary excretion was calculated as a
parameter of saliuretic activity. The ratio Na+/K+ was calcu-
lated for natriuretic activity. The ratio Cl/(Na + K) was calcu-
lated to estimate carbonic anhydrase inhibition (Somova et al.,
2003).2.8. Statistical analysis
All values were expressed as mean values ± SEM (standard
error of mean) and data were analyzed by applying an analysis
of variance (ANOVA) followed by Student’s t-test. The results
were considered statistically signiﬁcant if P< 0.05.3. Results
3.1. Effects on urine output and diuretic activity
The details of urine volume, diuretic action, and diuretic activ-
ity are presented in Table 1. From the result, it appears that P.
harmala exhibited diuretic activity at all doses like furosemide
at 5 h and 24 h, and its effect was dose dependent.
The total urine volume over the period of 5 h and 24 h was
measured for the P. harmalamethanolic extracts, (150, 300 and
450 mg/kg), reference diuretic (furosemide) and normal con-
trol. Furosemide and P. harmala increased the urine ﬂow sig-
niﬁcantly at 5 h and 24 h (P< 0.05) when compared with
control rats. The high dose excreted more than two fold the
volume of urine as compared to control.
The diuretic activity of a drug is considered nil if it is less
than 0.72, little if it is between 0.72 and 1.00, moderate if it
is within 1.00–1.50, and good if it is above 1.50. In this respect,
P. harmala exhibits good diuretic activity.
Table 1 Effect of methanolic extract of P. harmala L. on urine volume in Wistar albino rats at 5 h and 24 h interval.
Groups At 5 h after drug administration At 24 h after drug administration
Urine
volume (mL)
Diuretic
actiona
Diuretic
activityb
Urine
volume (mL)
Diuretic
actiona
Diuretic
activityb
Control (2 ml/kg) 1.53 ± 0.12 1.00 – 4.67 ± 0.51 1.00 –
Furosemide (10 mg/kg) 3.85 ± 0.25* 2.52 1.00 8.90 ± 0.45* 1.91 1.00
MEPH (150 mg/kg) 2.87 ± 0.11* 1.87 0.75 6.67 ± 0.19* 1.43 0.75
MEPH (300 mg/kg) 3.17 ± 0.28* 2.07 0.82 8.03 ± 0.45* 1.72 0.90
MEPH (450 mg/kg) 3.57 ± 0.19* 2.33 0.93 10.17 ± 0.95* 2.18 1.14
Values are expressed as mean ± SEM.
a Diuretic action = urine volume of test group/urine volume of control group.
b Diuretic activity = urine volume of test group/urine volume of furosemide group.
* Signiﬁcant change at P< 0.05 with respect to control rats.
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Urinary pH and conductivity were measured at 24 h (Fig. 1).
The urinary pH of control rats was 5.79 ± 0.07. The urine
pH after administration of P. harmala extract, at doses of
150, 300 and 450 mg/kg body weight were 7.83 ± 0.10, 7.97
± 0.16 and 8.47 ± 0.18, respectively at 24 h urine sample.
Furosemide increased the urine pH 8.17 ± 0.35, thus making
the urine more alkaline.
Conductivity of control rats was reported 12.62 ± 0.33 at
24 h collected urine sample. Conductivity of urine of furose-
mide treated rats was signiﬁcantly increased to 20.09 ± 0.13
(P< 0.01). P. harmala extract treated rats’ urine conductivity,
at doses of 150, 300 and 450 mg/kg was 15.44 ± 1.42, 18.55
± 1.35 and 19.60 ± 0.55, respectively.
3.3. Effects on electrolyte excretion
The diuretic responses with its electrolyte excretion potency of
the methanolic P. harmala extract were highly moderate in
comparison to normal control rats except lowest dose
(150 mg/kg). The P. harmala extract at doses of 300 and
450 mg/kg showed a signiﬁcant increase in Na+, K+ and
Cl excretion. The results of urinary electrolyte excretion after0 
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Figure 1 Effect of methanolic extract of P. harmala L. on
urinary pH and conductivity of Wistar albino rats at 24 h of
sample collection. Values are mean ± SEM. *P< 0.05, signiﬁcant
against the control group.treatment of P. harmala extract were comparable to the furo-
semide group (Table 2).3.4. Effects on natriuretic, saliuretic and carbonic anhydrase
inhibition
Table 3 depicts the results for natriuretic, saliuretic activity
and carbonic anhydrase inhibition. The furosemide (10 mg/
kg) and methanolic extract of P. harmala at doses (300 and
450 mg/kg) showed potent natriuretic and saliuretic activity
as compared to normal control. Methanolic extract of P. har-
mala didn’t show carbonic anhydrase inhibition in our study.4. Discussion
In the present study, the diuretic effect of three doses of
methanolic extract of P. harmala was evaluated in Wistar
albino rats. The results indicate that P. harmala at all dose
levels (150, 300 and 450 mg/kg) signiﬁcantly increased urine
output in a dose-dependent manner over a period of 5 h and
24 h. Therefore, good diuretic activity was observed among
rats treated with furosemide and P. harmala extracts at all
doses, except 150 mg/kg dose, wherein moderate activity was
observed. The diuretic activities of the extracts were found to
be highly potent when compared to the normal control group.
However, signiﬁcant differences in urinary excretion followed
by diuretic action and diuretic activity were observed. It
showed that the extract action was time and dose dependent.
This can be explained by kinetic differences of the active prin-
ciple presence in the extracts. Nilveses et al. (1989), reported
that an increment of the urine output in rats might result from
high potassium content in the plant extract. The pH values
were also alkaline as compared with control.
P. harmala extract increased the urinary excretion of
sodium, potassium and chloride ions signiﬁcantly. Therefore,
P. harmala has been shown to possess signiﬁcant saliuretic
and natriuretic effects (Asgarpanah and Ramezanloo, 2012).
All doses except 150 mg/kg of the methanolic extract of P.
harmala resulted in a signiﬁcant increase in urine volume,
Na+, K+, and Cl ion excretion as compared to the normal
control group. This effect may be due to the synergistic mech-
anism of the [HCO3
/Cl], [HCO3
+/H+] and the [Na+/H+]
antiporter, leading to diuresis (Dubois and Geiling, 1959). This
is a characteristic of high ceiling diuretic. Furosemide acts by
Table 2 Effect of methanolic extract of P. harmala L. on urinary electrolyte excretion of Wistar albino rats at 24 h urine sample
collection.
Groups Urinary Na+a
(mmol/L)
Urinary K+a
(mmol/L)
Urinary Cla
(mmol/L)
Na+ indexb K+ indexb Cl indexb
Control (2 ml/kg) 110.14 ± 9.12 58.49 ± 4.74 78.46 ± 4.29 1.00 1.00 1.00
Furosemide (10 mg/kg) 196.48 ± 12.53* 119.84 ± 14.27* 141.75 ± 7.97* 1.78 2.05 1.81
MEPH (150 mg/kg) 141.29 ± 5.47* 75.38 ± 3.10 87.11 ± 6.72 1.28 1.29 1.11
MEPH (300 mg/kg) 160.25 ± 6.12* 86.73 ± 3.70* 98.97 ± 4.99* 1.45 1.48 1.26
MEPH (450 mg/kg) 185.78 ± 17.12* 104.91 ± 6.23* 114.89 ± 5.43* 1.69 1.79 1.46
a Values are expressed as mean ± SEM.
b Index = excretion in test group/excretion in control group.
* Signiﬁcant change at P< 0.05 with respect to control rats.
Table 3 Effect of methanolic extract of P. harmala L. on natriuretic effect, saluretic effect and carbonic anhydrase inhibition of
Wistar albino rats at 24 h of urine sample collection.
Groups Saluretic eﬀect
(Na + Cl)a
Natriuretic eﬀect
(Na/K)a
CAI
(Cl/[Na++ K+])a
Saluretic
indexb
Natriuretic
indexb
CAI indexc
Control (2 ml/kg) 188.60 ± 10.75 1.98 ± 0.28 0.47 ± 0.03 1.00 1.00 1.00
Furosemide (10 mg/kg) 338.23 ± 13.15* 1.79 ± 0.25 0.46 ± 0.03 1.79 0.90 0.97
MEPH (150 mg/kg) 228.40 ± 10.09 1.91 ± 0.15 0.40 ± 0.03 1.21 0.96 0.85
MEPH (300 mg/kg) 259.22 ± 1.31* 1.85 ± 0.04 0.41 ± 0.04 1.37 0.93 0.86
MEPH (450 mg/kg) 300.68 ± 16.15* 1.81 ± 0.20 0.41 ± 0.03 1.59 0.91 0.86
a Values are expressed as mean ± SEM.
b Index = excretion in test group/excretion in control group.
c CAI, carbonic anhydrase inhibition.
* Signiﬁcant change at P< 0.05 with respect to control rats.
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of Henle (Shinkawa et al., 1993).
The natural compounds present in P. harmala are harmine
and harmaline, which are responsible for the various proper-
ties, (Berrougui et al., 2006). However, it is still not clear
whether harmine or harmaline is responsible for the diuretic
effects of P. harmala. Therefore, there is a need of further
research to ﬁnd out the active principles responsible for the
diuretic activities.
In the light of the above mentioned study, we can report
that the methanol extract of P. harmala is an effective diuretic
and also resulted in increased sodium, potassium and chloride
ions in urine; which correlate well with the traditional use of
the plant as a diuretic. The observations showed, P. harmala
had a diuretic spectrum similar to that of furosemide.
5. Conclusion
This study conﬁrms the signiﬁcant diuretic activity of the
methanolic extract of P. harmala. during the measurement per-
iod of the study (24 h). However, further studies are recom-
mended for explaining the mechanism of diuretic activity
and chronic toxicity.
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